BFNH — BioForce Nanosciences Holdings Balance Sheet
0.000.00%
- $16.92m
- $16.92m
Annual balance sheet for BioForce Nanosciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.04 | 0.011 | 0.001 | 0.001 | 0.001 |
Prepaid Expenses | |||||
Total Current Assets | 0.04 | 0.011 | 0.001 | 0.001 | 0.001 |
Total Assets | 0.04 | 0.011 | 0.001 | 0.001 | 0.001 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.4 | 0.873 | 1.35 | 1.82 | 2.3 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.4 | 0.873 | 1.35 | 1.82 | 2.3 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.36 | -0.862 | -1.35 | -1.82 | -2.3 |
Total Liabilities & Shareholders' Equity | 0.04 | 0.011 | 0.001 | 0.001 | 0.001 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |